K. Kowal

发表

Phase I trial of interferon-γ (IFN-γ) retroviral vector administered intratumorally to patients with metastatic melanoma

J. Nemunaitis, M. Pike, D. Ando, 1999, Cancer Gene Therapy.

Characterization of Vero cells.

C. Weeks-Levy, S. Mento, M. Ritchey, 1988, Journal of biological standardization.

Temperature-sensitive host-dependent mutants of Sindbis virus.

V. Stollar, K. Kowal, 1981, Virology.

Induction of interferon by temperature-sensitive mutants of Newcastle disease virus.

J. Youngner, K. Kowal, 1978, Virology.

Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays.

S. Mento, D. Jolly, M. Printz, 1995, Gene therapy.

Differential sensitivity of infectious and defective-interfering particles of Sindbis virus to ultraviolet irradiation.

V. Stollar, K. Kowal, 1980, Virology.

Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma.

J. Nemunaitis, W. Meyer, D. Martineau, 1998, Cancer gene therapy.

Evidence for localization of biologically active recombinant retroviral vector to lymph nodes in mice injected intramuscularly.

S. Chada, S. Mento, W. Edwards, 1996, Gene therapy.

Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver.

K. Brown, A. Covey, L. Brody, 2006, Human gene therapy.

Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanoma.

J. Nemunaitis, M. Pike, D. Ando, 1999, Cancer gene therapy.